Jeffreys, N., Horgan, C., Watts, K., Whitworth, K., Church, H., Rust, S., Booth, C., Buckland, K., Balbirnie-Cumming, K., Holley, R., Bigger, B., Jones, S., Wynn, R. (2025). Ex-vivo modification of autologous CD34+ HSPCs using a CD11B-directed lentiviral vector encoding APOEII-tagged human IDS leads to supraphysiological enzyme activity and early biochemical correction of neuronopathic mucopolysaccharidosis type II patients. Blood. https://doi.org/10.1182/blood-2025-384